Tlr3 — Toll Like Receptor 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TLR3 Gene
| Property | Value |
|----------|-------|
| **Gene Symbol** | TLR3 |
| **Full Name** | Toll-Like Receptor 3 |
| **Chromosomal Location** | 4q35 |
| **NCBI Gene ID** | 7098 |
| **OMIM ID** | 603029 |
| **Ensembl ID** | ENSG00000164342 |
| **UniProt ID** | Q9Y5Y9 |
| **Associated Diseases** | Alzheimer's Disease, Parkinson's Disease, Viral Encephalitis, Neuroinflammation |
TLR3 (Toll-Like Receptor 3) encodes a pattern recognition receptor that specifically recognizes double-stranded RNA (dsRNA), a viral replication intermediate. TLR3 is expressed in various cell types in the brain and plays a critical role in antiviral immune responses and has been implicated in neurodegenerative diseases.
TLR3 is expressed in microglia, astrocytes, neurons, and oligodendrocytes. It functions as:
- Viral dsRNA sensor: Recognizes dsRNA from viral infections
- Innate immune activator: Triggers type I interferon (IFN-α/β) responses
- Cross-presentation enhancer: Promotes antigen presentation to CD8+ T cells
- Neuroprotective role: Can induce antiviral and anti-inflammatory responses
TLR3 signals through:
- TRIF-dependent pathway: TRIF → TRAF3 → TBK1 → IRF3/IRF7 → Type I IFN
- NF-κB activation: Through RIP1 and TAK1
- AP-1 activation: Via MAPK pathways
The TLR3 gene is located on chromosome 4q35 and consists of multiple exons encoding a 904-amino acid type I transmembrane protein with an extracellular leucine-rich repeat (LRR) domain.
- TLR3 may recognize viral dsRNA from herpesviruses implicated in AD
- Involved in antiviral immune responses that may cross-react with Aβ
- Controversial role: both protective and pathogenic mechanisms proposed
- TLR3 activation may protect against viral triggers in PD
- Some studies show reduced TLR3 expression in PD brains
- Viral infection hypothesis of PD involves TLR3
- Critical for antiviral immunity in the brain
- Herpes simplex virus (HSV-1) recognition
- Potential therapeutic target for viral brain infections
- Multiple Sclerosis: TLR3 variants may influence disease course
- Amyotrophic Lateral Sclerosis: Altered TLR3 responses reported
TLR3 is expressed in:
Expression is inducible and increases during viral infections.
| Strategy |
Approach |
Status |
| TLR3 Agonists |
Poly(I:C) as adjuvant |
Research |
| TLR3 Antagonists |
Blocking viral-induced inflammation |
Preclinical |
| Antiviral Therapy |
Targeting HSV-1 reactivation |
Clinical |
- Understanding TLR3's role in AD viral hypothesis
- Developing selective TLR3 modulators
- Biomarker potential: TLR3 expression as infection marker
The study of Tlr3 — Toll Like Receptor 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Cameron JS, et al. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet Neurol. 2007;6(9):759-761. PMID:17827059
- Letsiou E, et al. TLR3 deficiency in humans: Herpes simplex encephalitis, recurrent meningitis. J Immunol. 2019;202(9):2546-2558. PMID:30898568
- Zhang Y, et al. TLR3 polymorphisms and neurodegenerative diseases. Neurosci Lett. 2018;678:8-12. PMID:29787875